Pfizer says it is now testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn’t appear strong enough for some of the children.
December 17, 2021 GMT
An eight-year-old child receives a second dose of the Pfizer COVID-19 vaccine at Northwest Community Church in Chicago, Saturday, Dec. 11, 2021. Pfizer is adding an extra dose of its COVID-19 vaccine for babies and preschoolers enrolled in a study of the shots. Pfizer and its partner BioNTech announced, Friday, Dec. 17, they were adding a third dose to the study after a preliminary analysis found 2- to 4-year-olds didn't have as strong an immune response as expected.
Pfizer announced the change after a preliminary analysis found 2- to 4-year-olds didn’t have as strong an immune response as expected to the very low-dose shots the company is testing in the youngest children. Pfizer and its partner BioNTech said if the three-dose study is successful, they plan to apply for emergency authorization sometime in the first half of 2022.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
CDC recommends Pfizer, Moderna COVID-19 shots over J&J's | AP NewsMost Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday. The strange clotting problem has caused nine confirmed deaths after J&J vaccinations — while the Pfizer and Moderna vaccines don't come with that risk and also appear more effective, said advisers to the Centers for Disease Control and Prevention.
Consulte Mais informação »
Covid-19: Nisra records increase in Covid-related deathsThe agency's Covid deaths total, based on mentions of the virus on death certificates, is 3,937.
Consulte Mais informação »
Pfizer files for full FDA approval of COVID-19 vaccine in adolescentsPfizer Inc and its German partner BioNTech SE said on Thursday they have filed for full approval of their COVID-19 vaccine with the U.S. Food and Drug Administration to include adolescents aged 12 to 15.
Consulte Mais informação »
Pfizer is testing a 3rd COVID-19 vaccine dose in young kidsPfizer and BioNTech are testing a third dose of their COVID-19 vaccine in an ongoing trial of children ages 6 months to under 5 years, the companies announced F
Consulte Mais informação »
Pfizer Testing Extra COVID-19 Vaccine Dose For Children Under 5The addition of an extra dose came after a preliminary analysis found 2- to 4-year-olds didn't have as strong an immune response as expected.
Consulte Mais informação »